Clinical Trial Update: Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Beclomethasone Dipropionate + Formoterol MDI versus Budesonide + Formoterol DPI in bronchial asthma; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Asthma

Drugs mentioned

• Beclomethasone Dipropionate/Formoterol (Beclomethasone dipropionate/formoterol)
• Symbicort (budesonide/formoterol)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Bronchial Asthma | Phase 3 | Status: COMPLETED